Literature DB >> 30941402

Opioids and Infectious Diseases: A Converging Public Health Crisis.

Tara A Schwetz1, Thomas Calder1, Elana Rosenthal2, Sarah Kattakuzhy2, Anthony S Fauci1.   

Abstract

A converging public health crisis is emerging because the opioid epidemic is fueling a surge in infectious diseases, such as human immunodeficiency virus infection with or without AIDS, the viral hepatitides, infective endocarditis, and skin and soft-tissue infections. An integrated strategy is needed to tailor preventive and therapeutic approaches toward infectious diseases in people who misuse and/or are addicted to opioids and to concurrently address the underlying predisposing factor for the infections-opioid use disorder. This commentary highlights the unique and complementary roles that the infectious diseases and substance use disorder communities can play in addressing this crisis of dual public health concerns. Published by Oxford University Press for the Infectious Diseases Society of America 2019.

Entities:  

Keywords:  Infectious diseases; opioid use disorder; opioids; substance use disorder

Mesh:

Substances:

Year:  2019        PMID: 30941402      PMCID: PMC6941614          DOI: 10.1093/infdis/jiz133

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

Review 1.  Opioids and the immune system - friend or foe.

Authors:  Lisanne Mirja Plein; Heike L Rittner
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

2.  Helping to End Addiction Over the Long-term: The Research Plan for the NIH HEAL Initiative.

Authors:  Francis S Collins; Walter J Koroshetz; Nora D Volkow
Journal:  JAMA       Date:  2018-07-10       Impact factor: 56.272

3.  Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study.

Authors:  Andrew D Wiese; Marie R Griffin; William Schaffner; C Michael Stein; Robert A Greevy; Edward F Mitchel; Carlos G Grijalva
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

4.  Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases: A Nested Case-Control Study.

Authors:  Andrew D Wiese; Marie R Griffin; William Schaffner; C Michael Stein; Robert A Greevy; Edward F Mitchel; Carlos G Grijalva
Journal:  Ann Intern Med       Date:  2018-02-13       Impact factor: 25.391

5.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Authors:  Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

6.  Hospitalizations Related To Opioid Abuse/Dependence And Associated Serious Infections Increased Sharply, 2002-12.

Authors:  Matthew V Ronan; Shoshana J Herzig
Journal:  Health Aff (Millwood)       Date:  2016-05-01       Impact factor: 6.301

7.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming
Journal:  N Engl J Med       Date:  2016-07-18       Impact factor: 91.245

8.  Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users.

Authors:  William A Zule; Christine Oramasionwu; Donna Evon; Sayaka Hino; Irene A Doherty; Georgiy V Bobashev; Wendee M Wechsberg
Journal:  Am J Drug Alcohol Abuse       Date:  2016-06-10       Impact factor: 3.829

Review 9.  Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

Authors:  Georgina J MacArthur; Eva van Velzen; Norah Palmateer; Jo Kimber; Anastasia Pharris; Vivian Hope; Avril Taylor; Kirsty Roy; Esther Aspinall; David Goldberg; Tim Rhodes; Dagmar Hedrich; Mika Salminen; Matthew Hickman; Sharon J Hutchinson
Journal:  Int J Drug Policy       Date:  2013-08-21

Review 10.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

View more
  25 in total

1.  Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.

Authors:  Elana S Rosenthal; Rachel Silk; Poonam Mathur; Chloe Gross; Rahwa Eyasu; Laura Nussdorf; Kristi Hill; Christopher Brokus; Aaron D'Amore; Nadeera Sidique; Phyllis Bijole; Miriam Jones; Randy Kier; Dana McCullough; David Sternberg; Kristen Stafford; Junfeng Sun; Henry Masur; Shyamasundaran Kottilil; Sarah Kattakuzhy
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

2.  Use of Pre-exposure Prophylaxis Among People Who Inject Drugs: Exploratory Findings of the Interaction Between Race, Homelessness, and Trust.

Authors:  Xin Zhou; Frederick L Altice; Divya Chandra; Elizabeth Didomizio; Michael M Copenhaver; Roman Shrestha
Journal:  AIDS Behav       Date:  2021-03-22

3.  Transcriptomic Analysis Reveals Receptor Subclass-Specific Immune Regulation of CD8+ T Cells by Opioids.

Authors:  Claire Mazahery; Saba Valadkhan; Alan D Levine
Journal:  Immunohorizons       Date:  2020-07-16

4.  Chronic Methadone Use Alters the CD8+ T Cell Phenotype In Vivo and Modulates Its Responsiveness Ex Vivo to Opioid Receptor and TCR Stimuli.

Authors:  Claire Mazahery; Bryan L Benson; Angélica Cruz-Lebrón; Alan D Levine
Journal:  J Immunol       Date:  2020-01-22       Impact factor: 5.422

5.  Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.

Authors:  Roman Shrestha; Elizabeth E DiDomizio; Rayne S Kim; Frederick L Altice; Jeffrey A Wickersham; Michael M Copenhaver
Journal:  J Subst Abuse Treat       Date:  2020-06-15

6.  Care cascade for patients with opioid use disorder and serious injection related infections.

Authors:  Anand Upadhyaya; Laura R Marks; Evan S Schwarz; Stephen Y Liang; Michael J Durkin; David B Liss
Journal:  Toxicol Commun       Date:  2021-02-10

7.  Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder.

Authors:  Nikhil Seval; Cynthia A Frank; Alain H Litwin; Prerana Roth; Meredith A Schade; Martina Pavlicova; Frances R Levin; Kathleen T Brady; Edward V Nunes; Sandra A Springer
Journal:  Contemp Clin Trials       Date:  2021-04-07       Impact factor: 2.261

8.  Gender differences in association of prescription opioid use and mortality: A propensity-matched analysis from the REasons for Geographic And Racial Differences in Stroke (REGARDS) prospective cohort.

Authors:  Yulia Khodneva; Joshua Richman; Stefan Kertesz; Monika M Safford
Journal:  Subst Abus       Date:  2019-12-20       Impact factor: 3.716

9.  Musculoskeletal Disorders, Pain Medication, and in-Hospital Mortality among Patients with COVID-19 in South Korea: A Population-Based Cohort Study.

Authors:  Tak-Kyu Oh; In-Ae Song; Joon Lee; Woosik Eom; Young-Tae Jeon
Journal:  Int J Environ Res Public Health       Date:  2021-06-24       Impact factor: 3.390

10.  A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections.

Authors:  Laura R Marks; Satish Munigala; David K Warren; David B Liss; Stephen Y Liang; Evan S Schwarz; Michael J Durkin
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.